Molecular analysis has revealed extensive intra-tumor heterogeneity in human cancer samples, but cannot identify cell-to-cell variations within the tissue microenvironment. In contrast, in situ analysis can identify genetic aberrations in phenotypically defined cell subpopulations while preserving tissue-context specificity. GoIFISH is a widely applicable, user-friendly system tailored for the objective and semi-automated visualization, detection and quantification of genomic alterations and protein expression obtained from fluorescence in situ analysis. In a sample set of HER2-positive breast cancers GoIFISH is highly robust in visual analysis and its accuracy compares favorably to other leading image analysis methods. GoIFISH is freely available at www.sourceforge.net/projects/goifish/.
Quantifying cell-to-cell heterogeneity in the tissue contextIntra-tumor heterogeneity is currently accepted as a hallmark of cancer, being present in virtually all tumor traits [1]. Sensitive molecular techniques developed in the last few years have allowed a detailed genetic and phenotypic deconvolution of intra-tumor heterogeneity. These include genome-wide analysis of bulk tumor samples to describe evolutionary trajectories in relapsed tumors and genomic divergence between primary tumors and metastases [2][3][4], as well as single-cell genomic profiling [2,5]. However, despite methodological improvements in the molecular characterization of single cells, the accurate interpretation of intra-tumor heterogeneity requires the inference of cell-to-cell variability within a particular tissue context, which can only be directly assessed by in situ analysis. Microenvironmental constraints within spatially restricted areas of a tumor can exert differential selective pressures, leading to the manifestation and the selection of different phenotypes and particular genotypes. For instance, different oxygen levels, the presence the development of objective analytical tools that minimize scoring subjectivity and facilitate the quantification of multiple traits in single cells while preserving context specificity. The implementation of these tools in both basic and translational research will advance our understanding of tumor biology and will facilitate biomarker discovery and validation.GoIFISH: quantifying tumor heterogeneity in IFISH images For application to IFISH, accurate segmentation at the nuclear, membrane and spot level are critical for subsequent analysis, which often interrogates clonal populations or evaluates relationships between protein and genomic expression. Objective integration of protein expression and copy number requires not only accurate segmentation, but also the separation of normal cells from tumor cells, and appropriate background subtraction associated with auto-fluorescence. Very few existing softwares allow manual alterations of small inaccuracies in cell segmentation and often incorrect cell classification results cannot be changed. Visual scoring by a trained observer (e.g. pathologist) is the gold...